|
MC-1 LEAD PRODUCT
MC-1 is a naturally occurring small molecule that in both preclinical and clinical studies has shown potential for treating various forms of cardiovascular disease. The properties of this protective, naturally-occurring molecule were discovered by internationally acclaimed researcher, Naranjan S. Dhalla, Ph.D.,
Distinguished Professor and Director, Institute of Cardiovascular Sciences,
St. Boniface General Hospital Research Centre, Faculty of Medicine,
University of Manitoba.
Medicure is currently evaluating MC-1's potential benefit as a monotherapy and/or fixed dose combination (MC-4232 & MC-4262) for the treatment of hypertension, type II diabetes and dyslipidemia.
|
|
Management Team 
